Krishna Institute of Medical Sciences' Q2 FY 2025-26 Quarterly Results
- 16 Nov 2025
Result Summary
- Krishna Institute of Medical Sciences Ltd reported a 9.8% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 23.3%.
- Its expenses for the quarter were up by 13.4% QoQ and 39.9% YoY.
- The net profit decreased 15.3% QoQ and decreased 40.3% YoY.
- The earnings per share (EPS) of Krishna Institute of Medical Sciences Ltd stood at 1.67 during Q2 FY 2025-26.
Financial Statments for Q2 FY 2025-26
Total Income | 964.90 | 878.70 | 782.30 | 9.8% | 23.3% |
Total Expenses | 867.80 | 765.00 | 620.10 | 13.4% | 39.9% |
Profit Before Tax | 96.80 | 113.70 | 162.20 | -14.9% | -40.3% |
Tax | 24.80 | 28.70 | 41.50 | -13.6% | -40.2% |
Profit After Tax | 72.00 | 85.00 | 120.70 | -15.3% | -40.3% |
Earnings Per Share | 1.67 | 1.96 | 2.68 | -14.8% | -37.7% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Krishna Institute of Medical Sciences Ltd (KIMS) is a prominent player in the healthcare industry in India. As a leading healthcare provider, KIMS operates a network of multi-specialty hospitals offering a wide range of medical services including cardiology, orthopedics, neurology, and oncology among others. The company is known for its state-of-the-art facilities and expert medical practitioners. Recent developments have focused on expanding its service offerings and increasing its footprint through strategic acquisitions and opening new hospital branches. However, specific recent developments pertaining to the company's activities or market positioning in the past year are not available in the provided data.
Revenue
For the quarter ending Q2FY26, Krishna Institute of Medical Sciences Ltd reported a total income of ₹964.90 crores. This reflects a 9.8% increase compared to the previous quarter (Q1FY26), where the total income was ₹878.70 crores. Furthermore, there is a significant 23.3% year-over-year growth in total income when compared to Q2FY25, which recorded a total income of ₹782.30 crores. This upward trend in revenue indicates a robust growth trajectory over the recent quarters and past year, highlighting the company's ability to enhance its income generation capabilities.
Profitability
The profitability metrics for Krishna Institute of Medical Sciences Ltd show a decrease over the analyzed periods. The Profit Before Tax (PBT) for Q2FY26 is reported at ₹96.80 crores, which is a decline of 14.9% from the previous quarter's PBT of ₹113.70 crores. On a year-over-year basis, the PBT fell by 40.3% compared to Q2FY25, which recorded a higher PBT of ₹162.20 crores. The Profit After Tax (PAT) also experienced similar declines, with Q2FY26 reporting ₹72.00 crores, down by 15.3% quarter-over-quarter from ₹85.00 crores in Q1FY26, and a 40.3% decrease year-over-year from ₹120.70 crores in Q2FY25. Earnings per Share (EPS) followed suit, declining to ₹1.67 in Q2FY26 from ₹1.96 in Q1FY26 and ₹2.68 in Q2FY25, reflecting a decrease of 14.8% QoQ and 37.7% YoY.
Operating Metrics
The company's total expenses for Q2FY26 were ₹867.80 crores, marking a 13.4% increase from Q1FY26's expenses of ₹765.00 crores. Year-over-year, there is a 39.9% rise from Q2FY25, where the total expenses were ₹620.10 crores. This notable increase in expenses outpaced the growth in total income, impacting overall profitability. The tax expenditure for Q2FY26 was ₹24.80 crores, a decrease of 13.6% from Q1FY26's tax of ₹28.70 crores, and a 40.2% decrease from Q2FY25's tax of ₹41.50 crores. These changes in tax expenses align with the observed trends in profit metrics. The company's operating performance reflects significant variations in key financial metrics over the quarters and year, which are critical for understanding its financial health and operational efficiency.